Jared Barsky

Array ( [id] => 6510153 [patent_doc_number] => 20100210723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Lipase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/662405 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8386 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210723.pdf [firstpage_image] =>[orig_patent_app_number] => 12662405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9888994 [patent_doc_number] => 08975247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Methods and compositions of treating a flaviviridae family viral infection' [patent_app_type] => utility [patent_app_number] => 13/376483 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44733 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171303 [patent_doc_number] => 20120107323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'KINASE PROTEIN BINDING INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/256112 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 29347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107323.pdf [firstpage_image] =>[orig_patent_app_number] => 13256112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712194 [patent_doc_number] => 20120004321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Orally Disintegrating Tablet' [patent_app_type] => utility [patent_app_number] => 13/256798 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3940 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6088006 [patent_doc_number] => 20110217331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Inactivation of Reverse Transcriptases By Azido-diarylpyrimidines' [patent_app_type] => utility [patent_app_number] => 12/718726 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11262 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217331.pdf [firstpage_image] =>[orig_patent_app_number] => 12718726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351051 [patent_doc_number] => 20100249180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ISOTHIAZOLOPYRIDINONES USEFUL FOR THE TREATMENT OF (INTER ALIA) CYSTIC FIBROSIS' [patent_app_type] => utility [patent_app_number] => 12/711474 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17991 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249180.pdf [firstpage_image] =>[orig_patent_app_number] => 12711474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448316 [patent_doc_number] => 20100144895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/707373 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6136 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144895.pdf [firstpage_image] =>[orig_patent_app_number] => 12707373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995043 [patent_doc_number] => 08518927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Chemically programmed vaccination' [patent_app_type] => utility [patent_app_number] => 13/148658 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 38 [patent_no_of_words] => 16401 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742066 [patent_doc_number] => 20120020876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'HEDGEHOG PATHWAY INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/144992 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21084 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020876.pdf [firstpage_image] =>[orig_patent_app_number] => 13144992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772442 [patent_doc_number] => 08426398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Conjugates of noscapine and folic acid and their use in treating cancer' [patent_app_type] => utility [patent_app_number] => 13/142908 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11301 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007927 [patent_doc_number] => 20110059958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/744736 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118915 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059958.pdf [firstpage_image] =>[orig_patent_app_number] => 12744736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618257 [patent_doc_number] => 20130023569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'Use of Deferiprone for Treatment and Prevention of Iron-Related Eye Disorders' [patent_app_type] => utility [patent_app_number] => 13/138263 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7881 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13138263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016984 [patent_doc_number] => 20110224298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM' [patent_app_type] => utility [patent_app_number] => 13/128393 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4922 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224298.pdf [firstpage_image] =>[orig_patent_app_number] => 13128393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10031491 [patent_doc_number] => 09072791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Photostabilized pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/121852 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12554 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048722 [patent_doc_number] => 20110207770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/058792 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15754 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207770.pdf [firstpage_image] =>[orig_patent_app_number] => 13058792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113591 [patent_doc_number] => 20110190324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS OF TREATING ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/997963 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19739 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190324.pdf [firstpage_image] =>[orig_patent_app_number] => 12997963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186611 [patent_doc_number] => 20110124670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis' [patent_app_type] => utility [patent_app_number] => 13/054011 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5145 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124670.pdf [firstpage_image] =>[orig_patent_app_number] => 13054011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375878 [patent_doc_number] => 08680143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Orally active curcuminoid compounds' [patent_app_type] => utility [patent_app_number] => 13/002588 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7822 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13002588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568051 [patent_doc_number] => 20110288114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES OR CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/001281 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8213 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288114.pdf [firstpage_image] =>[orig_patent_app_number] => 13001281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003466 [patent_doc_number] => 20110118350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'COMPOSITION FOR PREVENTING CARDIOVASCULAR EVENT IN HIGH-RISK PATIENT' [patent_app_type] => utility [patent_app_number] => 12/993715 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8114 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118350.pdf [firstpage_image] =>[orig_patent_app_number] => 12993715 [rel_patent_id] =>[rel_patent_doc_number] =>)